Este resumen localizado ofrece una visión basada en evidencia de este tema. El contenido completo se mantiene en inglés para consistencia editorial.

Ipamorelin vs CJC-1295 (No DAC): GHSR vs GHRH Signaling

Ipamorelin and CJC-1295 (No DAC) are one of the most frequently discussed peptide pairs in GH-axis research because they stimulate a related endocrine outcome through different receptor pathways. Ipamorelin targets GHSR-1a (ghrelin receptor). CJC-1295 No DAC signals through pituitary GHRH receptors. This dual-entry architecture is what makes them useful for pathway-isolation studies and complementary protocols.

Side-by-Side

The DAC Question (Why "No DAC" Matters Here)

CJC-1295 exists in two forms: with DAC (drug affinity complex — a modification that binds albumin and extends half-life to several days) and without DAC (short-acting, matches natural pulsatile GHRH timing more closely). This comparison uses No DAC intentionally, because the pulse-timing logic of a stack with ipamorelin depends on a short-acting GHRH analog. See the dedicated CJC-1295 DAC vs No DAC framing for why that distinction matters.

Why This Pair Is So Common in GH-Axis Protocols

Because ipamorelin and CJC-1295 No DAC engage separate receptors within the same axis, they enable cleaner tests of pathway contribution and reduce overreliance on a single signaling node. In pulse-window experiments where temporal control drives interpretation, pairing ghrelin-receptor triggering with GHRH-pathway support produces a more physiologic signal shape.

Comparator Design: Isolate First, Stack Second

Good methodology separates ipamorelin and CJC-1295 before combining them. Isolate each compound in its own arm to characterize pulse behavior; then add a combined arm to test additive or synergistic signaling. Skipping the isolation step introduces confounds that make the stack arm hard to interpret.

Bottom Line

Ipamorelin and CJC-1295 No DAC are paired so often because their receptors are genuinely complementary — not because they are redundant. The research value is in understanding which signaling layer each compound represents, then designing protocols that respect that architecture.

Educational content only. Not medical advice.